Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre,Randomized,Double-blind, Multiple-dose, Placebo-controlled, Parallel-Group Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy With Blood Stasis Syndrome and Deficiency of Qi-Yin Syndrome

NCT01373476 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT01373476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre,Randomized,Double-blind, Multiple-dose, Placebo-controlled, Parallel-Group Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy With Blood Stasis Syndrome and Deficiency of Qi-Yin Syndrome
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
March 31, 2013
Enrollment
240 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic eye problems, diabetic retinopathy, retinal disorders